TipRanks
Advertisement
Advertisement
Annovis Bio announces full enrollment for buntanetap trial
PremiumThe FlyAnnovis Bio announces full enrollment for buntanetap trial
2M ago
Annovis Bio promotes Cheng Fang to chief scientific officer
Premium
The Fly
Annovis Bio promotes Cheng Fang to chief scientific officer
3M ago
Annovis Bio Shareholders Approve Governance and Compensation Changes
Premium
Company Announcements
Annovis Bio Shareholders Approve Governance and Compensation Changes
3M ago
Closing Bell Movers: Roblox up 4% on buyback, Keysight gains on earnings
PremiumThe FlyClosing Bell Movers: Roblox up 4% on buyback, Keysight gains on earnings
4M ago
Annovis Bio announces common stock and warrants offering, no amount given
Premium
The Fly
Annovis Bio announces common stock and warrants offering, no amount given
4M ago
Annovis Bio Prices Registered Direct Offering to Fund Trials
Premium
Company Announcements
Annovis Bio Prices Registered Direct Offering to Fund Trials
5M ago
Annovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
PremiumRatingsAnnovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
7M ago
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
Premium
Company Announcements
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
7M ago
Annovis Bio secures DSMB approval to advance Phase 3 trial of buntanetap
Premium
The Fly
Annovis Bio secures DSMB approval to advance Phase 3 trial of buntanetap
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100